CHECKMATE-057
Regimen
- Experimental
- nivolumab
- Control
- docetaxel
Population
Pretreated advanced non-sq NSCLC
Key finding
mOS 12.2 vs 9.4 mo, HR 0.73 (0.59-0.89); PD-L1 enrichment signal
Source: PMID 26412456
Timeline
- Enrollment start: 2012-11-02 📎
Guideline citations
- NCCN NSCLC Version 5.2026 (p.179)